Konrad Pesudovs

Causes of vision loss worldwide, 1990-2010: a systematic analysis

BACKGROUND Data on causes of vision impairment and blindness are important for development of public health policies, but comprehensive analysis of change in prevalence over time is lacking. METHODS We did a systematic analysis of published and unpublished data on the causes of blindness (visual acuity in the better eye less than 3/60) and moderate and severe vision impairment ([MSVI] visual acuity in the better eye less than 6/18 but at least 3/60) from 1980 to 2012. We estimated the proportions of overall vision impairment attributable to cataract, glaucoma, macular degeneration, diabetic retinopathy, trachoma, and uncorrected refractive error in 1990-2010 by age, geographical region, and year. FINDINGS In 2010, 65% (95% uncertainty interval [UI] 61-68) of 32·4 million blind people and 76% (73-79) of 191 million people with MSVI worldwide had a preventable or treatable cause, compared with 68% (95% UI 65-70) of 31·8 million and 80% (78-83) of 172 million in 1990. Leading causes worldwide in 1990 and 2010 for blindness were cataract (39% and 33%, respectively), uncorrected refractive error (20% and 21%), and macular degeneration (5% and 7%), and for MSVI were uncorrected refractive error (51% and 53%), cataract (26% and 18%), and macular degeneration (2% and 3%). Causes of blindness varied substantially by region. Worldwide and in all regions more women than men were blind or had MSVI due to cataract and macular degeneration. INTERPRETATION The differences and temporal changes we found in causes of blindness and MSVI have implications for planning and resource allocation in eye care. FUNDING Bill & Melinda Gates Foundation, Fight for Sight, Fred Hollows Foundation, and Brien Holden Vision Institute.

Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease

Aims: To evaluate the efficacy of 50% autologous serum drops against conventional treatment in ocular surface disorders refractory to normal treatments in a prospective randomised crossover trial. Method: Patients fulfilling ophthalmological and haematological entry criteria were randomised to either 3 months of autologous serum 50% followed by 3 months of their conventional treatment, or 3 months of conventional treatment, followed by 3 months of autologous serum. Clinical assessments, including Schirmer’s test, rose Bengal, and fluorescein staining, were carried out on entry and at monthly intervals. Impression cytology was performed at entry, 3 and 6 months. Grading was carried out on degrees of squamous metaplasia and goblet cell density. Subjective comfort was recorded daily using the “faces” scale. These categorical scores were converted to linear measurement using Rasch analysis. Statistical analysis was carried out using Wilcoxon’s signed rank test and ANOVA. Results: 16 patients were recruited with 31 eyes studied. The ocular surface diseases chiefly included Sjögren’s syndrome (n = 6) and keratoconjunctivitis sicca (n = 5). Impression cytology available in 25 of 31 eyes showed significant improvement on serum treatment, p<0.02. Rasch weighted faces scores were statistically significantly better with serum, p<0.01. Conclusion: The results of this randomised study provide further evidence of the beneficial effects of autologous serum in severe ocular surface disorders. For most of these patients, autologous serum was superior to conventional treatment for improving ocular surface health and subjective comfort.

The development, assessment, and selection of questionnaires.

Patient-reported outcome measurement has become accepted as an important component of comprehensive outcomes research. Researchers wishing to use a patient-reported measure must either develop their own questionnaire (called an instrument in the research literature) or choose from the myriad of instruments previously reported. This article summarizes how previously developed instruments are best assessed using a systematic process and we propose a system of quality assessment so that clinicians and researchers can determine whether there exists an appropriately developed and validated instrument that matches their particular needs. These quality assessment criteria may also be useful to guide new instrument development and refinement. We welcome debate over the appropriateness of these criteria as this will lead to the evolution of better quality assessment criteria and in turn better assessment of patient-reported outcomes.

Anterior segment biometry with the pentacam: comprehensive assessment of repeatability of automated measurements

PURPOSE: To comprehensively assess the reliability of automated Pentacam (Oculus, Inc.) measurements. SETTING: Flinders Eye Centre, Flinders Medical Centre, Bedford Park, South Australia, Australia. METHODS: Both eyes of 35 normal volunteers were tested twice on the same day by 2 different observers. All automated values were recorded, and manual analysis of topographic maps was performed only to overrule variance in corneal thickness due to pupil decentration altering the central reference point. Repeatability was determined with Bland‐Altman limits of agreement and reported as the coefficient of repeatability (COR = ±1.96 standard deviation of differences). Relative repeatability (RR) was calculated as a percentage of the ratio of COR to the mean. RESULTS: Overall, repeatability was good. Corneal curvature, reported in diopters, showed good repeatability anteriorly (simulated keratometry mean COR±0.28D; RR=0.64%) and posteriorly (COR±011D; RR=1.85%). Peripheral corneal curvature was more reliable when calculated by the sagittal (axial) method (RR=1.57%) than by the tangential (meridional) method (RR=2.38%). Keratometric power deviation was less reliable (RR=16.39%). Anterior chamber measurements showed good reliability (RR=3.07%‐5.68%) except for anterior chamber angle (RR=14.41%). Pupil diameter showed poor reliability (RR=25.77%). Central corneal thickness was comparable at pupil center and corneal vertex, but peripheral repeatability was much better when centered on the corneal vertex (COR±16.00μm; RR=2.56%) than at pupil center (COR±26.28μm; RR=4.23%). CONCLUSIONS: Pentacam corneal curvature and anterior chamber parameters were highly repeatable, but pupil measurements had poor repeatability. Peripheral pachymetry readings were affected by pupil decentration and required manual analysis using the corneal vertex as the point of reference to achieve good repeatability.

Global Prevalence of Vision Impairment and Blindness: Magnitude and Temporal Trends, 1990–2010

PURPOSE Vision impairment is a leading and largely preventable cause of disability worldwide. However, no study of global and regional trends in the prevalence of vision impairment has been carried out. We estimated the prevalence of vision impairment and its changes worldwide for the past 20 years. DESIGN Systematic review. PARTICIPANTS A systematic review of published and unpublished population-based data on vision impairment and blindness from 1980 through 2012. METHODS Hierarchical models were fitted fitted to estimate the prevalence of moderate and severe vision impairment (MSVI; defined as presenting visual acuity <6/18 but ≥ 3/60) and the prevalence of blindness (presenting visual acuity <3/60) by age, country, and year. MAIN OUTCOME MEASURES Trends in the prevalence of MSVI and blindness for the period 1990 through 2010. RESULTS Globally, 32.4 million people (95% confidence interval [CI], 29.4-36.5 million people; 60% women) were blind in 2010, and 191 million people (95% CI, 174-230 million people; 57% women) had MSVI. The age-standardized prevalence of blindness in older adults (≥ 50 years) was more than 4% in Western Sub-Saharan Africa (6.0%; 95% CI, 4.6%-7.1%), Eastern Sub-Saharan Africa (5.7%; 95% CI, 4.4%-6.9%), South Asia (4.4%; 95% CI, 3.5%-5.1%), and North Africa and the Middle East (4.6%; 95% CI, 3.5%-5.8%), in contrast to high-income regions with blindness prevalences of ≤ 0.4% or less. The MSVI prevalence in older adults was highest in South Asia (23.6%; 95% CI, 19.4%-29.4%), Oceania (18.9%; 95% CI, 11.8%-23.7%), and Eastern and Western Sub-Saharan Africa and North Africa and the Middle East (95% CI, 15.9%-16.8%). The MSVI prevalence was less than 5% in all 4 high-income regions. The global age-standardized prevalence of blindness and MSVI for older adults decreased from 3.0% (95% CI, 2.7%-3.4%) worldwide in 1990 to 1.9% (95% CI, 1.7%-2.2%) in 2010 and from 14.3% (95% CI, 12.1%-16.2%) worldwide to 10.4% (95% CI, 9.5%-12.3%), respectively. When controlling for age, womens prevalence of blindness was greater than mens in all world regions. Because the global population has increased and aged between 1990 and 2010, the number of blind has increased by 0.6 million people (95% CI, -5.2 to 5.3 million people). The number with MSVI may have increased by 19 million people (95% CI, -8 to 72 million people) from 172 million people (95% CI, 142-198 million people) in 1990. CONCLUSIONS The age-standardized prevalence of blindness and MSVI has decreased in the past 20 years. However, because of population growth and the relative increase in older adults, the blind population has been stable and the population with MSVI may have increased

Statistical methods for conducting agreement (comparison of clinical tests) and precision (repeatability or reproducibility) studies in optometry and ophthalmology

Citation information: McAlinden C, Khadka J & Pesudovs K. Statistical methods for conducting agreement (comparison of clinical tests) and precision (repeatability or reproducibility) studies in optometry and ophthalmology. Ophthalmic Physiol Opt 2011, 31, 330–338. doi: 10.1111/j.1475‐1313.2011.00851.x

Penetrating keratoplasty for keratoconus: visual outcome and success.

OBJECTIVE To determine the long-term effect on vision of penetrating keratoplasty performed for keratoconus. DESIGN Retrospective noncomparative case series. PARTICIPANTS All patients with keratoconus who received a corneal graft and who remained in our center for follow-up and visual rehabilitation during the study period. INTERVENTION Penetrating keratoplasty was performed in 93 eyes of 78 patients. MAIN OUTCOME MEASURES Graft survival, visual acuity, and astigmatism. RESULTS One (1.08%) graft failure was encountered over a mean follow-up of 46 months. Mean preoperative (best corrected) and postoperative visual acuity is (best-tolerated correction) were 0.9 (20/160) and 0.24 (20/80) logMAR, respectively. Visual acuity in 86% of eyes was 0.3 logMAR (20/40) or better at the latest follow-up, with 67% of eyes being corrected with spectacles. Mean preoperative corneal power by keratometry was more than 52 diopters (D) in 83% of eyes; mean postoperative corneal power was 45 +/- 2 D. No significant predictors of postgraft astigmatism were found. Mean preoperative and postoperative best-eye acuities of the better eye were 0.32 (20/40-1) and 0.18 (20/32+1) logMAR, respectively (P < 0.001). CONCLUSIONS Graft survival was excellent. A corrected visual acuity of 20/40 or better was obtained in 86% of eyes. Astigmatism could not be predicted from preoperative factors. Visual acuity measured in the better eye improved by 0.14 logMAR (1.4 lines), implying an overall functional gain for the patient.

Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe: 1990–2010

Background To assess prevalence and causes of blindness and vision impairment in high-income regions and in Central/Eastern Europe in 1990 and 2010. Methods Based on a systematic review of medical literature, prevalence of moderate and severe vision impairment (MSVI; presenting visual acuity <6/18 but ≥3/60 in the better eye) and blindness (presenting visual acuity <3/60) was estimated for 1990 and 2010. Results Age-standardised prevalence of blindness and MSVI decreased from 0.2% to 0.1% (3.314 million to 2.736 million people) and from 1.6% to 1.0% (25.362 million to 22.176 million), respectively. Women were generally more affected than men. Cataract was the most frequent cause of blindness in all subregions in 1990, but macular degeneration and uncorrected refractive error became the most frequent causes of blindness in 2010 in all high-income countries, except for Eastern/Central Europe, where cataract remained the leading cause. Glaucoma and diabetic retinopathy were fourth and fifth most common causes for blindness for all regions at both times. Uncorrected refractive error, followed by cataract, macular degeneration, glaucoma and diabetic retinopathy, was the most common cause for MSVI in 1990 and 2010. Conclusions In highly developed countries, prevalence of blindness and MSVI has been reduced by 50% and 38%, respectively, and the number of blind people and people with MSVI decreased by 17.4% and 12.6%, respectively, even with the increasing number of older people in the population. In high-income countries, macular degeneration has become the most important cause of blindness, but uncorrected refractive errors continue to be the leading cause of MSVI.

The usefulness of Vistech and FACT contrast sensitivity charts for cataract and refractive surgery outcomes research

Aim: To investigate the repeatability and sensitivity of two commonly used sine wave patch charts for contrast sensitivity (CS) measurement in cataract and refractive surgery outcomes. Methods: The Vistech CS chart and its descendant, the Functional Acuity Contrast Test (FACT), were administered in three experiments: (1) Post-LASIK and age matched normal subjects; (2) Preoperative cataract surgery and age matched normal subjects; (3) Test-retest repeatability data in normal subjects. Results: Contrast sensitivity was similar between post-LASIK and control groups and between the Vistech and FACT charts. The percentage of subjects one month post-LASIK achieving the maximum score across spatial frequencies (1.5, 3, 6, 12, 18 cycles per degree) were (50, 33, 13, 13, 0 respectively) for FACT, but only (0, 0, 13, 4, 0 respectively) for Vistech. A small number of cataract patients also registered the maximum score on the FACT, but up to 60% did not achieve the minimum score. Test-retest intraclass correlation coefficients varied from 0.28 to 0.64 for Vistech and 0.18 to 0.45 for FACT. Bland-Altman limits of agreement across spatial frequencies were between ±0.30 and ±0.85 logCS for Vistech, and ±0.30 to ±0.75 logCS for FACT. Discussion: The Vistech was confirmed as providing poorly repeatable data. The FACT chart, likely because of a smaller step size, showed slightly better retest agreement. However, the reduced range of scores on the chart due to the smaller step size led to ceiling (post-LASIK) and floor (cataract) effects. These problems could mask subtle differences between groups of patients with near normal visual function as found post-refractive or cataract surgery. The Vistech and FACT CS charts are ill suited for refractive or cataract surgery outcomes research.

Catquest-9SF patient outcomes questionnaire Nine-item short-form Rasch-scaled revision of the Catquest questionnaire

PURPOSE: To assess and optimize the Catquest questionnaire for measuring patient‐reported outcomes of cataract surgery using Rasch analysis. SETTING: Fifty‐eight ophthalmic surgical units in Sweden. METHODS: Catquest questionnaires (n = 21 364) from the Swedish National Cataract Register were selected and randomized to 2 groups. Data from 10 486 questionnaires were comprehensively Rasch analyzed using a 4‐Andrich rating scale model in Winsteps software. A revised version of Catquest was developed (Catquest‐9SF) and tested in 10 886 patients for validity and responsiveness to cataract surgery. RESULTS: Only the visual disability subscale formed a valid measurement scale. This could be enhanced through the addition of the 2 global assessment items; however, the symptoms and frequency of performing the activities items did not contribute to the measurement. The 9‐item short‐form version (Catquest‐9SF) had ordered response thresholds and good person separation (2.65) and was largely free from differential item functioning. All items fit a single overall construct (infit range, 0.75 to 1.29; outfit range, 0.70 to 1.39) and unidimensional by principal components analysis. The items were well targeted to the preoperative participants (0.34 logit difference in means). The score correlated with visual acuity (r = 0.43 preoperatively; r = 0.48 postoperatively) and was highly responsive to cataract surgery (preoperatively −0.32 ± 2.15 logits; postoperatively −3.21 ± 2.50 logits (P<.0001). CONCLUSIONS: The 9‐item Rasch‐scaled Catquest‐9SF was highly valid in measuring visual disability outcomes of cataract surgery. Its brevity makes it suited to routine clinical use, and a raw‐data to Rasch‐measure conversion simplifies application.